Establishment of an induced pluripotent stem cell line from a patient with CHARGE syndrome carrying a CHD7 (p.L1151Gfs*17) mutation

Stem Cell Res. 2020 May:45:101774. doi: 10.1016/j.scr.2020.101774. Epub 2020 Mar 20.

Abstract

CHARGE syndrome is a rare disease caused by a genetic disorder. The clinical features of this syndrome include coloboma of the eye, heart anomaly, choanal atresia, retardation of mental and somatic development, microphallus, ear abnormalities and/or deafness. CHD7 is the main causative gene for CHARGE syndrome. In this study, we generated an induced pluripotent stem cell (iPSC) line from the dermal fibroblasts of a 1.5-year-old girl, carrying a de novo mutation (CHD7;NM_017780;c.3449_3450delTC;p.L1151Gfs*17). This iPSC line will be a useful tool for investigating the pathogenesis and for developing treatment for this complicated syndrome.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CHARGE Syndrome* / genetics
  • DNA Helicases / genetics
  • DNA-Binding Proteins / genetics
  • Female
  • Humans
  • Induced Pluripotent Stem Cells*
  • Infant
  • Mutation

Substances

  • DNA-Binding Proteins
  • DNA Helicases
  • CHD7 protein, human